Moderna shares surge 120% on cancer vaccine results: Why the stock is soaring
Edit ProfileSubscribe NowSaved ArticlesFollowingMy ReadsSign out Moderna stock jumps 120% after cancer vaccine trial win: What investors need to knowModerna stock surged after its mRNA cancer vaccine showed positive Phase 3 results with Merck’s Keytruda, boosting hopes for a new melanoma treatment.Updated on: Aug 19, 2026, 20:46:32 ISTBy Durva MorePrefer HTon Google Moderna stock surged…